We are studying how hematopoietic cell fate is specified, maintained, and eventually modified or reversed. Inspired from the fields of stem cell biology, immunology, and cancer we use an interdisciplinary approach to mechanistically understand hematopoietic and immune cell identities and translate our findings into novel gene and cell therapies.
Merging Stem Cells with Immunology by Cell Fate Reprogramming. Learn more about our research lines:
Single-Cell Transcriptional Profiling Informs Efficient Reprogramming of Human Somatic Cells to Cross-Presenting Dendritic Cells
Fábio F. Rosa, Cristiana F. Pires, Ilia Kurochkin, Evelyn Halitzki, Tasnim Zahan, Nejc Arh, Olga Zimmermannová, Alexandra G. Ferreira, Hongzhe Li, Stefan Karlsson, Stefan Scheding, Carlos-Filipe Pereira
March 4, 2022 / Vol. 7, No. 69
Cell Fate Reprogramming in the Era of Cancer Immunotherapy
Olga Zimmermannova, Inês Caiado, Alexandra G. Ferreira and Carlos-Filipe Pereira
July 21, 2021 / Volume 12, Article 714822
Frontiers in Immunology
We are a diverse group – molecular biologists, MDs, PharmDs, tumor immunologists, stem cell biologists and computational scientists – at all career stages. We architect strategies to dissect and manipulate immune cell identity.
Looking for an opportunity? Join our international team!
Ilia Kurochkin Awarded a CRI Fellowship
Pereira Lab researcher Ilia Kurochkin was awarded an Immuno-Informatics Postdoctoral Fellowship by the Cancer Research Institute (CRI).
The Pereira Lab was Awarded an ERC Proof of Concept Grant
The Pereira Lab was today announced as the receiver of a Proof of Concept Grant from the European Research Council (ERC).
The Pereira Lab Was Awarded the NovoNordisk Distinguished Innovator Grant
The Pereira Lab has been awarded with a grant of 6.000.000 DKK from the NovoNordisk foundation.